首页> 外文期刊>Human mutation >ERCC4 variants identified in a cohort of patients with segmental progeroid syndromes
【24h】

ERCC4 variants identified in a cohort of patients with segmental progeroid syndromes

机译:ERCC4在节段性突发综合征的患者队列中鉴定的ercc4变体

获取原文
获取原文并翻译 | 示例
       

摘要

Pathogenic variants in genes, which encode DNA repair and damage response proteins, result in a number of genomic instability syndromes with features of accelerated aging. ERCC4 (XPF) encodes a protein that forms a complex with ERCC1 and is required for the 5 incision during nucleotide excision repair. ERCC4 is also FANCQ, illustrating a critical role in interstrand crosslink repair. Pathogenic variants in this gene cause xeroderma pigmentosum, XFE progeroid syndrome, Cockayne syndrome (CS), and Fanconi anemia. We performed massive parallel sequencing for 42 unsolved cases submitted to the International Registry of Werner Syndrome. Two cases, each carrying two novel heterozygous ERCC4 variants, were identified. The first case was a compound heterozygote for: c.2395CT (p.Arg799Trp) and c.388+1164+792+795del (p.Gly130Aspfs*18). Further molecular and cellular studies indicated that the ERCC4 variants in this patient are responsible for a phenotype consistent with a variant of CS. The second case was heterozygous for two variants in cis: c.[1488AT; c.2579CA] (p.[Gln496His; Ala860Asp]). While the second case also had several phenotypic features of accelerated aging, we were unable to provide biological evidence supporting the pathogenic roles of the associated ERCC4 variants. Precise genetic causes and disease mechanism of the second case remains to be determined.
机译:在编码DNA修复和损伤蛋白的基因中的病原变体导致许多基因组不稳定性综合征,其具有加速老化的特征。 ERCC4(XPF)编码一种与ERCC1形成复合物的蛋白质,并且在核苷酸切除修复期间5个切口所需的蛋白质。 ERCC4也是FANCQ,说明了Interstrand Crosslink修复中的关键作用。该基因的致病变体导致Xeroderma Pigmentosum,XFE Progeroid综合征,Cockayne综合征(CS)和Fanconi贫血。我们对提交的42个未解决的案件进行了大规模的并行测序,提交给Werner综合症的国际登记处。鉴定了两种患者,每种携带两种新的杂合子ERCC4变体。第一种情况是化合物杂合子,用于:C.2395C> T(P.ARG799TRP)和C.388 + 1164 + 792 + 795del(P.Gly130aspFS * 18)。进一步的分子和细胞研究表明该患者中的ERCC4变体负责与Cs的变体一致的表型。第二种情况是CIS中的两个变体的杂合子:C. [1488A& t; C.2579C& a](p。[gln496his; ala860asp])。虽然第二种病例也有几种加速老化的表型特征,但我们无法提供支持相关ERCC4变体的致病作用的生物学证据。第二个案例的精确遗传原因和疾病机制仍有待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号